Agree To Buy Elevance Health At $165, Earn 3% Using Options

The piece evaluates selling a January 2028 put on Elevance Health (ELV) at a $165 strike, noting the $4.90 premium yields a 1.5% annualized return and would produce a net cost basis of $160.10 if assigned. With ELV trading at $340.70 and the strike ~51.6% below current price, assignment requires a steep decline; the author cites a trailing 12‑month volatility of 40% to help assess risk. The analysis emphasizes that put sellers do not participate in upside unless assigned, framing the trade as limited-yield, downside-risk exposure rather than a substitute for share ownership.

Analysis

Contrarian angles: The consensus selling of ultra‑deep OTM long‑dated puts understates the value of ELV’s durable MA franchise and investment income — large permanent impairment is unlikely absent systemic policy shock. The market may be underpricing near‑term policy tail risk but overpricing long‑dated structural collapse; this divergence creates opportunities in time‑limited defined‑risk option strategies. Historical parallels (2017–2019 policy noise) show rapid recoveries after confirmed rate stability. Unintended consequence: widespread use of low‑premium deep OTM put selling can lead to forced accumulation at unattractive basis if a correlated sector drawdown occurs, creating liquidity squeezes.

Key Decisions for Investors

• Do NOT sell the Jan‑2028 ELV $165 put at $4.90 — premium (1.5% annualized) is insufficient for a 51.6% downside; gap risk and tail exposure make this a negative expected‑value trade.
• Establish a 1–3% portfolio long position in ELV (ticker: ELV) on a two‑tranche basis: 50% at market and add 50% if price falls to $310 (10% drop), with a stop loss at 22% below average entry and a 12–18 month target gain of 15–25%.
• Implement defined‑risk option income: sell 90‑day ELV put spread (sell $300 / buy $260) size equal to 0.5–1% notional to collect premium while capping assignment risk; roll or unwind if ELV trades below $280 or IV collapses >10 vols.
• If already long ELV, buy a 12‑18 month 25% downside protective put and fund by selling 6–12 month OTM calls (collar) to limit downside to ~20% while preserving upside; reassess after next CMS MA rate decision (expected within 30–90 days).
• Pair trade alternative: for sector‑neutral exposure, go long ELV 1.0x and short UNH 0.75x (or another large peer) to capture idiosyncratic ELV upside while reducing macro/MA policy beta; size total net exposure to 1–2% portfolio and rebalance at earnings or policy events.